Cargando…

Tolerability, safety, and preliminary antitumor activity of fuzuloparib in combination with SHR-1316 in patients with relapsed small cell lung cancer: a multicenter, open-label, two-stage, phase Ib trial

BACKGROUND: Second-line treatment options for small cell lung cancer (SCLC) are limited. Preclinical research shows that inhibition of poly (ADP-ribose) polymerase (PARP) could upregulate programmed death-ligand 1 (PD-L1), and thus render cancer cells more sensitive to immune checkpoint inhibitors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yanjun, Huang, Zhiyu, Fang, Jian, Liu, Anwen, Lu, Hongyang, Yu, Xinmin, Chen, Kaiyan, Xu, Xiaoling, Ma, Xinjing, Shi, Wei, Kim, Young Hak, Hakozaki, Taiki, Addeo, Alfredo, Shen, Yu, Li, Shaorong, Fan, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271434/ https://www.ncbi.nlm.nih.gov/pubmed/35832454 http://dx.doi.org/10.21037/tlcr-22-356

Ejemplares similares

A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer
por: Zhang, Qingyuan, et al.
Publicado: (2022)

Fuzuloparib: First Approval
por: Lee, Arnold
Publicado: (2021)

Correction to: Fuzuloparib: First Approval
por: Lee, Arnold
Publicado: (2021)

Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective
por: Li, Ning, et al.
Publicado: (2022)

19-Benzoyloxy-13,16-seco-ent-beyeran 13,16-lactone
por: Cai, Jin, et al.
Publicado: (2010)

SHR‐1316, an anti‐PD‐L1 antibody, plus chemotherapy as the first‐line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase 2 study
por: Mu, Lan, et al.
Publicado: (2021)

1316. Uncommon Presentations of Common Variable Immunodeficiency
por: Alok, Akankcha, et al.
Publicado: (2021)

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer
por: Wu, Yawen, et al.
Publicado: (2022)

1316. An Integrative Approach to Teaching History of Medicine in Medical School
por: Slosar-Cheah, Magdalena, et al.
Publicado: (2018)

1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
por: Katsube, Takayuki, et al.
Publicado: (2020)

1316. Clinical Utility of Pharmacogenomic Testing in Refractory Coccidioidal Meningitis
por: Blair, Janis E, et al.
Publicado: (2023)

Sintilimab plus anlotinib as second‐ or third‐line therapy in metastatic non‐small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single‐arm, phase II trial
por: Chen, Kaiyan, et al.
Publicado: (2023)

Correction to Lancet Glob Health 2020; 8: e1316–25
Publicado: (2022)

The 1316T>C missenses mutation in MTHFR contributes to MTHFR deficiency by targeting MTHFR to proteasome degradation
por: Liu, Xi, et al.
Publicado: (2020)

P1316: ASSESSING GENOMIC SAFETY OF ANTIVIRAL NUCLEOSIDE ANALOGS IN HEMATOPOIETIC STEM CELLS
por: Peci, F., et al.
Publicado: (2022)

Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
por: Xu, Yanjun, et al.
Publicado: (2021)

A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis
por: Liu, Yaxin, et al.
Publicado: (2023)

The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
por: Yu, Qian, et al.
Publicado: (2019)

1316. Gathering Trauma Narratives: A Qualitative Study on the Impact of Traumas on People Living with HIV (PLWH)
por: Pierson, Doris, et al.
Publicado: (2019)

Spatial Memory in Spontaneously Hypertensive Rats (SHR)
por: Sontag, Thomas-A., et al.
Publicado: (2013)

Mechanism of SQQX Decoction's Protective Effect on SHR: A Serum Metabolomics-Based Analysis
por: Wu, Jiayun, et al.
Publicado: (2020)

Cardioprotective Regimen of Adaptation to Chronic Hypoxia Diversely Alters Myocardial Gene Expression in SHR and SHR-mt(BN) Conplastic Rat Strains
por: Nedvedova, Iveta, et al.
Publicado: (2019)

Insufficient hypothalamic angiotensin-converting enzyme 2 is associated with hypertension in SHR rats
por: Wang, Kun, et al.
Publicado: (2017)

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women
por: Xu, Yi, et al.
Publicado: (2022)

Vasorelaxant and Hypotensive Effects of Cheonwangbosimdan in SD and SHR Rats
por: Kim, Bumjung, et al.
Publicado: (2018)

A mass balance study of [(14)C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans
por: Zhang, Hua, et al.
Publicado: (2023)

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
por: Wang, Xinmin, et al.
Publicado: (2021)

Root canal morphology of 1316 premolars from Brazilian individuals: an in vivo analysis using cone-beam computed tomography
por: Lemos, Marília C, et al.
Publicado: (2022)

Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China
por: Nie, Jing, et al.
Publicado: (2023)

PD-L1 expression in small cell lung cancer: should we designate it for assignment?
por: Hakozaki, Taiki
Publicado: (2021)

Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer
por: Hakozaki, Taiki
Publicado: (2022)

Quantitative spatial profiling of PD-1/PD-L1 interaction in patients with cancer
por: Hakozaki, Taiki
Publicado: (2023)

Antioxidant resveratrol restores renal sodium transport regulation in SHR
por: Javkhedkar, Apurva A, et al.
Publicado: (2015)

Quantification of platelets obtained by different centrifugation protocols in SHR rats()
por: Yazigi Junior, João Alberto, et al.
Publicado: (2015)

A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model
por: Tanaka, Kazunori, et al.
Publicado: (2014)

Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M
por: Berrou, Eliane, et al.
Publicado: (2015)

Transcriptomics of ivermectin response in Caenorhabditis elegans: Integrating abamectin quantitative trait loci and comparison to the Ivermectin-exposed DA1316 strain
por: Dube, Faruk, et al.
Publicado: (2023)

Membrane procoagulation and N‑terminomics/TAILS profiling in Montreal platelet syndrome kindred with VWF p.V1316M mutation
por: Agbani, Ejaife O., et al.
Publicado: (2023)

Association between the polymorphism (rs17222919, −1316T/G) of 5-lipoxygenase-activating protein gene (ALOX5AP) and the risk of stroke: A meta analysis
por: Ye, Hui, et al.
Publicado: (2018)

Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study
por: Xu, Yanjun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0jsld3g8838tp0lhu9ikbe0i40